ILMN Dec 2024 140.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

16.64

0.00

(0.00%)

As of 02:40PM EDT. Market open.

Loading interactive chart…

Zacks
OPK Gets Additional BARDA Funding to Develop Multispecific Antibodies
OPKO Health's receipt of the additional funding from BARDA is expected to explore the MSTAR platform to prepare for outbreaks and respond rapidly to emerging viral threats.
Zacks
EXAS Gains FDA Nod for Cologuard Plus, Progresses With CRC Screening
Per the findings of the pivotal BLUE-C study, the Cologuard Plus test of Exact Sciences stands out for its high sensitivity at a specificity of 94%.
PR Newswire
Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today unveiled its MiSeq™ i100 Series of sequencing systems, delivering unparalleled benchtop speed and simplicity to advance next-generation sequencing (NGS) for labs.